Los Angeles Capital Management
NAGE

Los Angeles Capital Management’s Niagen Bioscience NAGE Stock Holding History

Los Angeles Capital Management’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.12M Buy
481,442
+355,254
+282% +$1.92M 0.01% 492
2025
Q4 		$897K Sell
126,188
-91,922
-42% -$640K ﹤0.01% 668
2025
Q3 		$2.03M Buy
218,110
+173,235
+386% +$1.75M 0.01% 501
2025
Q2 		$647K Sell
44,875
-77,945
-63% -$770K ﹤0.01% 785
2025
Q1 		$847K Sell
122,820
-95,708
-44% -$601K ﹤0.01% 609
2024
Q4 		$1.16M Buy
+218,528
New +$1.2M ﹤0.01% 574
2021
Q3 		– Sell
-30,495
Closed -$301K – 1610
2021
Q2 		$301K Buy
+30,495
New +$266K ﹤0.01% 1385

Other funds holding NAGE

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.8B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return